NIH-funded research NIH-funded research

Using radical migration to create new medicines

Official title: Harnessing the Latent Potential of Radical Migration to Drive Synthetic Innovation

Funded at Pennsylvania State University, the · NIH-10940801 · Data updated 2026-11-12

This study is exploring new ways to make medicines more effectively, which could lead to better and more effective treatments for patients like you.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionPennsylvania State University, the
NIH-funded
Lab location1 site (University Park, United States)
Project startSeptember 1, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$383,884
NIH project number1R35GM155233-01
Project IDNIH-10940801 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for benefiting from this research include individuals who require new pharmaceutical treatments for their medical conditions.

Less likely to help

Patients who are not seeking new medication options or those with conditions that do not require pharmaceutical intervention may not benefit from this research.

What this research studies

This research focuses on developing innovative synthetic methods that utilize radical-mediated migrations to enhance the discovery and production of pharmaceuticals. By improving processes like olefin difunctionalizations and stereoselective α-functionalizations of carbonyls, the project aims to overcome existing technical challenges in pharmaceutical synthesis. Patients may benefit from new and more effective medications that can be produced through these advanced synthetic techniques.

Why it matters

Potential benefit: If successful, this research could lead to the development of new and more effective medications for various health conditions.

How similar studies have gone: Other research has shown promise in utilizing radical-mediated approaches for synthetic innovation, indicating potential for success in this novel application.

Where this research is happening

  • Pennsylvania State University, the
    University Park, United States
    Active

Researchers

  • Principal investigator: Nacsa, Eric — Pennsylvania State University, the
  • Study coordinator: Nacsa, Eric

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.